uptake kinetics after acetazolamide administration during moderate-and heavy-intensity exercise. J. Appl. Physiol. 85(4): 1384-1393, 1998.-Inhibition of carbonic anhydrase (CA) is associated with a lower plasma lactate concentration ([La Ϫ ] pl ) during fatiguing exercise. We hypothesized that a lower [La Ϫ ] pl may be associated with faster O 2 uptake (V O 2 ) kinetics during constant-load exercise. Seven men performed cycle ergometer exercise during control (Con) and acute CA inhibition with acetazolamide (Acz, 10 mg/kg body wt iv). On 6 separate days, each subject performed 6-min step transitions in work rate from 0 to 100 W (below ventilatory threshold, ϽV ET) or to a V O 2 corresponding to ϳ50% of the difference between the work rate at V ET and peak V O 2 (ϾV ET). Gas exchange was measured breath by breath. Trials were interpolated at 1-s intervals and ensemble averaged to yield a single response. The mean response time (MRT, i.e., time to 63% of total exponential increase) for on-and off-transients was determined using a two-(ϽV ET) or a three-component exponential model (ϾV ET). Arterialized venous blood was sampled from a dorsal hand vein and analyzed for [La Ϫ ] pl . MRT was similar during Con (31.2 Ϯ 2.6 and 32.7 Ϯ 1.2 s for on and off, respectively) and Acz (30.9 Ϯ 3.0 and 31.4 Ϯ 1.5 s for on and off, respectively) for work rates ϽV ET. At work rates ϾV ET, MRT was similar between Con (69.1 Ϯ 6.1 and 50.4 Ϯ 3.5 s for on and off, respectively) and Acz (69.7 Ϯ 5.9 and 53.8 Ϯ 3.8 s for on and off, respectively). On-and off-MRTs were slower for ϾV ET than for ϽV ET exercise.
DURING THE ADJUSTMENT to an abrupt increase in exercise intensity, pulmonary O 2 uptake (V O 2 ) increases with an initial rapid rise (phase 1) followed by an exponential increase (phase 2) to a new steady state (phase 3) if the exercise is of moderate intensity [i.e., below the ventilatory threshold (ϽV ET)]. For exercise intensities that engender a sustained lactic acidosis (i.e., ϾV ET), an additional increase in V O 2 of delayed onset leads to a steady-state V O 2 , which, if attained at all, is higher than predicted from the ϽV ET relationship between V O 2 and work rate (2, 6, 40, 41) . During the transition, the time constant () for phase 2 kinetics reflects the V O 2 at the muscle and, therefore, the contribution of oxidative phosphorylation to ATP resynthesis (1, 4, 5, 18) . Because oxidative phosphorylation does not meet the total energy requirements (i.e., O 2 deficit), the breakdown of high-energy phosphate stores [phosphocreatine (PCr)] and increases in anaerobic glycolysis provide the balance of energy necessary for maintaining ATP turnover (2) .
For moderate-intensity exercise, where a steadystate V O 2 is attained, Cerretelli and colleagues (11, 12) reported that the half time for V O 2 kinetics during the on-transition was slowed when accompanied by an accumulation of blood lactate (i.e., the early lactate concept). This suggested that increases in blood lactate concentration ([La Ϫ ]) during the on-response associated with step increases in work rate reflected increases in ATP production via anaerobic glycolysis and caused a slowing of O 2 utilization by the muscle (11, 12) . Casaburi and co-workers (8) also demonstrated a slowing of the V O 2 on-response during constant-load exercise not associated with sustained increases in blood [La Ϫ ]. These researchers suggested that transient increases in La Ϫ production may slow the rate of O 2 utilization by muscle early in exercise and, thereby, affect V O 2 kinetics (8) . These findings are consistent with earlier demonstrations of a slower V O 2 onresponse and greater O 2 deficit during the adjustment to moderate exercise under hypoxic than under normoxic conditions (23) . The slower V O 2 kinetics during hypoxia were associated with an increased reliance on anaerobic energy sources indicated by the lower muscle PCr and higher blood and muscle [La Ϫ ] at the end of exercise (23) . Thus the slowing of V O 2 kinetics during the on-response appears to be associated with increases in muscle and blood [La Ϫ ].
For step increases in work rate resulting in sustained increases in blood [La Ϫ ], V O 2 kinetics become more complex as an additional slow increase in V O 2 of delayed onset becomes evident. This V O 2 slow component has been shown to be highly correlated to the magnitude and rate of change of blood [La Ϫ ] (32). However, a mechanism directly linking the V O 2 slow component to the lactic acidosis or a related metabolic event has not been established (for review see Refs. 16 and 39) . There is evidence to suggest that overall V O 2 kinetics are slowed in association with increases in end-exercise blood [La Ϫ ] (2). Interestingly, if the V O 2 response is modeled so that the kinetics of phase 2 (i.e., rapid exponential rise) and phase 3 (i.e., slow component) are determined independently, the relationship between V O 2 kinetics and blood [La Ϫ ] is unclear. Compared with exercise intensities ϽV ET, the phase 2 V O 2 on-response has been shown to be slowed (29) or similar (2, 8) , despite significant increases in blood [La Ϫ ].
Inhibition of carbonic anhydrase (CA) with an acute administration of acetazolamide (Acz) compared with control is associated with lower peak blood [La Ϫ ] after short-term high-intensity exercise (21) . The metabolic consequence of this Acz-induced lowering of blood [La Ϫ ] during moderate-and heavy-intensity constant-load exercise has not been investigated. The lower blood [La Ϫ ] after CA inhibition may be due to a decreased rate of La Ϫ production, possibly by an increased flux of pyruvate through the pyruvate dehydrogenase complex and the subsequent oxidation of pyruvate. If the rate of pyruvate oxidation is increased, the kinetics of V O 2 may be expected to be faster after CA inhibition. Alternatively, CA inhibition may lead to acid-base changes on the extracellular surface of the sarcolemma that may impair the efflux of La Ϫ from the muscle to the blood (13) . Under this condition, V O 2 kinetics would not be expected to be altered by CA inhibition. We hypothesized that CA inhibition after an acute administration of Acz would be associated with a lower blood [La Ϫ ] as a consequence of a faster rate of adjustment of V O 2 (i.e., phase 2) at the start of moderate-and heavy-intensity exercise, suggesting that CA inhibition was associated with a greater flux through pyruvate dehydrogenase and not with an impaired efflux of La Ϫ . In addition, we hypothesized that the V O 2 slow component during heavy exercise would be reduced after Acz-induced CA inhibition in accordance with the lower blood [La Ϫ ].
METHODS

Subjects.
Seven healthy men participated in the study. The experimental protocol and all possible risks associated with participation in the study were outlined, and informed consent was obtained from each subject. The study was approved by the University's Review Board for Health Sciences Research Involving Human Subjects.
Material and methods. The subjects were studied on six separate occasions during control (Con) conditions and after acute Acz administration. The subjects reported to the laboratory after consuming only a light meal and abstaining from exercise and beverages containing caffeine for Ն12 h preceding the test. The exercise tests were performed at the same time of the day for each subject. To facilitate blood sampling and Acz administration, on one occasion during the Con studies and before each of the Acz studies the subjects rested supine while a percutaneous Teflon catheter (Angiocath, 21 gauge) was placed into a dorsal hand vein. The blood was arterialized by wrapping the hand and forearm in a heating pad. After 15 min of rest, a blood sample was drawn, then Acz was infused (10 mg/kg over a 3-min period). The administration of Acz was randomly ordered during the six visits. A placebo was not administered, because in our experience the side effects of Acz administration, although producing minor discomfort, are still noticeable by the subject. After an additional 30 min of rest (15 min supine and 15 min seated upright), a blood sample was drawn, and the subject moved to the cycle ergometer. Breath-by-breath measurements of gas exchange and ventilation were made throughout the exercise protocol; blood samples were obtained on one occasion during each of the two conditions at specific times during exercise (0, 15, 30, and 45 s and 1, 1.5, 2, 3, 4, and 6 min) and recovery (30 s and 1, 2, 4, and 6 min).
Preliminary testing of each subject consisted of an incremental exercise test (work rate was increased as a ramp function at 25 W/min) to volitional fatigue on an electromagnetically braked cycle ergometer (model H-300-R, Lode) for the determination of V ET and peak V O 2 (V O 2 peak ). The highest V O 2 averaged over a 20-s interval was taken as V O 2 peak . The V ET was defined as the V O 2 at which there was a systematic increase in the ventilatory equivalent for V O 2 (V E/V O 2 , where V E is ventilation) and end-tidal PO 2 , with no concomitant increase in the ventilatory equivalent for CO 2 output (V E/V CO 2 ) or decrease in end-tidal PCO 2 .
For the determination of V O 2 kinetics, subjects performed two step transitions to an absolute work rate ϽV ET (100 W) and one transition to a work rate ϾV ET. At ϾV ET, the work rate assigned was estimated to elicit a V O 2 corresponding to ϳ50% of the difference between the V O 2 at V ET and V O 2 peak :
Each step transition was 6 min in duration, with 6 min of loadless cycling between each bout. The exercise protocol was performed during three laboratory visits for each condition, resulting in six repetitions for the moderate-intensity exercise and three repetitions for the heavy-intensity exercise.
Inspired and expired airflow and volumes were measured during the exercise test by a low-resistance, low-dead-space (90 ml) bidirectional turbine and volume transducer (model VMM-110, Alpha Technologies); the volume signal was calibrated before each test with a syringe of known volume (990 ml). Respired gases were sampled continuously at the mouth (1 ml/s) by a mass spectrometer (model MGA-1100, PerkinElmer) for determination of the fractional concentrations of O 2 , CO 2 , and N 2 . The mass spectrometer was calibrated with precision-analyzed gas mixtures. Analog signals from the mass spectrometer and turbine transducer were sampled every 20 ms and stored on disk for later analysis. Breath-bybreath computations for V O 2 , V CO 2 , V E, and end-tidal PO 2 and PCO 2 were performed after accounting for delays in the analysis system and fluctuations in lung gas stores in the computer algorithms (7) . Corrections for temperature and water vapor were made for conditions measured near the mouth. Heart rate was monitored using an electrocardiogram with the electrodes placed in a modified V5 configuration.
Arterialized venous blood was drawn into syringes containing lithium heparin, mixed, placed in a slurry of ice and water, and analyzed after a short delay. Whole blood samples (200 µl) were analyzed (at 37°C) for plasma pH and the plasma [La Ϫ ] ([La Ϫ ] pl ) using selective electrodes (StatProfile 9 Plus Blood Gas-Electrolyte Analyzer, Nova Biomedical Canada); the electrodes were calibrated before each test and at regular intervals during analysis.
Data analysis. Breath-by-breath data obtained during the step increases in work rate were linearly interpolated at 1-s intervals, time aligned, and ensemble averaged to provide a single response for each subject. The model utilized to describe the kinetic response ( Fig. 1) provides an estimate of the baseline (G 0 ), gains (G 1 , G 2 , and G 3 ), time delays (TD 1 , TD 2 , and TD 3 ), and time constants ( 1 , 2 , and 3 ). For step changes in work rate ϽV ET, the kinetic parameters for the on-and off-transitions in work rate were determined as a function of time (t) using a two-component exponential model
where u 1 ϭ 0 for t Ͻ TD 1 , u 1 ϭ 1 for t Ͼ TD 1 , u 2 ϭ 0 for t Ͻ TD 2 , and u 2 ϭ 1 for t Ͼ TD 2 . For step changes in work rate ϾV ET, the kinetic parameters for the on-and off-transitions in work rate were determined using a three-component exponential model
]·u 3 (4) where u 1 ϭ 0 for t Ͻ TD 1 , u 1 ϭ 1 for t Ͼ TD 1 , u 2 ϭ 0 for t Ͻ TD 2 , u 2 ϭ 1 for t Ͼ TD 2 , u 3 ϭ 0 for t Ͻ TD 3 , and u 3 ϭ 1 for t Ͼ TD 3 . Model parameters were determined by least-squares nonlinear regression, in which the best fit was defined by minimization of the residual sum of squares. The overall time course of the response was determined from the mean response time (MRT), which is calculated from a weighted sum of TD and for each component. The MRT is equivalent to the time required to achieve ϳ63% of the difference between G 0 and the new steady-state value.
The magnitude and slope of the V O 2 slow component were determined as the difference between the V O 2 at the end of exercise and the V O 2 at 3 min of exercise [⌬V O 2(6-3 min) ], V O 2 at 3 min was taken as the mean V O 2 from 10 s before and 10 s after 3 min, and the end-exercise V O 2 was taken as the mean V O 2 during the last 20 s of exercise. The kinetics of the slow component were described by the parameter estimates derived from the three-component exponential model fit. Similarly, the change in [La Ϫ ] pl 5⌬[La Ϫ ] (6-3 min) 6 was determined as the difference between [La Ϫ ] pl at the end of exercise and at 3 min of exercise.
Statistics. Kinetic parameter estimates were analyzed using a two-way repeated-measures ANOVA for Con vs. Acz and on-vs. off-transitions as the main effects. Blood data were analyzed for condition and time effects using a two-way repeated-measures ANOVA. A significant F ratio was further analyzed using Student-Newman-Keuls post hoc analysis.
⌬V O 2(6-3 min) and ⌬[La Ϫ ] (6-3 min) were analyzed using Student's paired t-test. Statistical significance was accepted at P Ͻ 0.05. Values are means Ϯ SE.
RESULTS
Subjects.
The physical characteristics and peak values for the ramp exercise test are presented in Table 1 . The individual work rates for the constant-load exercise tests are presented in Table 2 . All subjects completed six repetitions at the ϽV ET work rate and three repetitions at the ϾV ET work rate for each condition. The work rates utilized during the constant-load tests were 100 W (73.5 Ϯ 2.9% V ET During moderate-intensity exercise ϽV ET, [La Ϫ ] pl increased above loadless cycling values during Con (P Ͻ 0.05, t Ն 7.5 min) and Acz (P Ͻ 0.05, t Ն 9 min; Fig.  2A ). At 2 min after the onset of exercise, [La Ϫ ] pl was higher during Con than during Acz (P Ͻ0.05), a difference that persisted until 2 min after the end of the exercise bout. Even at this moderate-intensity exercise, end-exercise [La Ϫ ] pl was higher during Con than during Acz (2.0 Ϯ 0.2 and 1.4 Ϯ 0.2 mmol/l, respectively). The [La Ϫ ] pl returned to resting values during the recovery period for Con (P Ͼ 0.05, t ϭ 18 min) and Acz conditions (P Ͼ 0.05, t Ն 13 min).
With the onset of ϾV ET exercise, [La Ϫ ] pl increased above loadless cycling values during Con (P Ͻ 0.05, t Ն 7.5 min) and Acz (P Ͻ 0.05, t Ն 8 min) and remained elevated for the remainder of the protocol (Fig. 2B) .
[La Ϫ ] pl was higher (P Ͻ 0.05) during Con than during Acz by 2 min of exercise and remained higher for the duration of exercise. End-exercise [La Ϫ ] pl was higher To determine the effect of CA inhibition on V O 2 kinetics, the confounding influence of the metabolic acidosis that occurs with chronic Acz administration was avoided by acute administration of Acz. Plasma pH, determined 30 min after infusion at rest, was not affected by the infusion of Acz (7.434 Ϯ 0.006 and 7.429 Ϯ 0.007 for Con and Acz, respectively). During 0-W pedaling, plasma pH was slightly, but significantly, higher (P Ͻ 0.05) during Con than during Acz (7.429 Ϯ 0.007 vs. 7.412 Ϯ 0.008). At the end of moderateintensity exercise, plasma pH decreased (P Ͻ 0.05) below loadless cycling values in Con and Acz; endexercise plasma pH was higher (P Ͻ 0.05) in Con than in Acz (7.413 Ϯ 0.005 vs. 7.390 Ϯ 0.007). Similarly, during heavy-intensity exercise, plasma pH decreased (P Ͻ 0.05) to end-exercise plasma pH values that were higher (P Ͻ 0.05) during Con than during Acz (7.353 Ϯ 0.011 vs. 7.335 Ϯ 0.012). When the plasma acid-base status was expressed as the difference in end-exercise plasma H ϩ concentration between Con and Acz, the difference, although significant (P Ͻ 0.05), was small (2.1 and 1.9 nmol/l for ϽV ET and ϾV ET, respectively).
V O 2 uptake kinetics. A summary of the model parameters derived for the V O 2 on-and off-response to a step increase of moderate-intensity exercise is presented in Table 3 . An example of the V O 2 response for a single subject during ϽV ET exercise is presented in Fig. 3 . The baseline value for V O 2 during 0-W pedaling (G 0 ) was similar between Con and Acz conditions. The total gain (G T
At the onset of moderate-intensity exercise, V O 2 increased similarly between Con and Acz, as indicated by the similar MRT (31.2 Ϯ 2.6 and 30.9 Ϯ 3.0 s during Con and Acz, respectively). In addition, no differences were observed in the model parameters for phase 1 (TD 1 and 1 ) or phase 2 (TD 2 and 2 ) for the V O 2 on-response between Con and Acz. The time course for the V O 2 off-response, as indicated by MRT, was similar to that of the V O 2 on-response during each condition. The model parameters (TD and ) for the V O 2 offresponse were similar to those for the V O 2 on-response for Con and Acz. The O 2 deficit (MRT · G T , on-transient) was not different between Con and Acz (500 Ϯ 40 and 503 Ϯ 56 ml, respectively). The O 2 debt (MRT · G T , off-transient) was similar between conditions (519 Ϯ 17 and 499 Ϯ 25 ml for Con and Acz, respectively) and was not different from the O 2 deficit in either condition.
The model parameters determined for the V O 2 onand off-response to a step increase to heavy-intensity exercise are summarized in Table 4 . An example of the V O 2 response for a single subject during ϾV ET exercise is presented in Fig. 4 . During 0-W pedaling, baseline V O 2 (G 0 ) was similar between Con and Acz. At the onset Moderate-intensity exercise resulted in a faster V O 2 on-response (P Ͻ 0.05) than did heavy-intensity exercise during Con and Acz, as indicated by the faster MRT and 2 (Tables 3 and 4) . During the off-response, V O 2 recovered faster during moderate-than during heavyintensity exercise during Con and Acz, as demonstrated by the slower MRT (Tables 3 and 4 Table 5 . No differences were observed in the magnitude [G 3 in Table 4 and ⌬V O 2(6-3 min) in 6 did not reach statistical significance (P ϭ 0.055).
DISCUSSION
In the present study, constant-load exercise was performed after acute Acz administration to examine the effect of CA inhibition on the kinetics of the V O 2 adjustment to and from moderate-and heavy-intensity cycling exercise. In agreement with previous studies (21), we showed that the acute administration of Acz to inhibit CA was associated with a lowering of [La Ϫ ] pl during moderate-and heavy-intensity constant-load exercise and recovery. However, in contrast to our hypotheses, the results of the present study demonstrate that 1) acute CA inhibition with Acz, despite lower [La Ϫ ] pl , did not affect the overall time course for V O 2 or phase 2 V O 2 kinetics during moderate-or heavy-intensity exercise and 2) the magnitude and time course of the V O 2 slow component were independent of the absolute increase in [La Ϫ ] pl .
Exercise was initiated 30 min after an infusion of Acz to examine the effects of CA inhibition alone without the confounding effects of a metabolic acidosis that usually develops with prolonged Acz administration (22, 37) . In the present study the small but significant acidosis that developed was probably not of any physiological significance. Although CA activity was not measured in the present study, it has previously been shown that CA inhibition is essentially complete in most body tissues at Acz doses of 5-20 mg/kg (24) . The Acz dose of 10 mg/kg used in the present study was similar to that in the work of Swenson and Maren (37) , in which they reported that the erythrocyte isozymes CA I and CA II were ϳ93.3 and 99.3% inhibited, respectively, with an Acz dose of 7-10 mg/kg. In addition, we observed slower V CO 2 kinetics after Acz administration, indicating that the dose and protocol used in this study effectively inhibited CA activity (unpublished observations).
Steady-state V O 2 . Inhibition of CA with an acute infusion of Acz did not affect steady-state V O 2 during loadless cycling or moderate-or heavy-intensity constant-load exercise (Tables 3 and 4) . These results are in agreement with previous studies that examined the effects of CA inhibition during submaximal exercise (28, 34, 36) . Studies using short-term high-intensity exercise (21, 22) or progressive exercise (34) report lower V O 2 peak with Acz. The reason for the lower V O 2 reported by Kowalchuk et al. (21) is not apparent, inasmuch as the maximum peak power, average power, and total work performed during the 30-s exercise bout in that study were not affected by Acz. However, the lower V O 2 peak reported for progressive maximal exercise may be a function of the reduced maximal work rate achieved with this type of protocol (34) . Interestingly, Stager and colleagues (36) reported a similar V O 2 peak during progressive maximal exercise, despite a significant reduction in peak work rate after Acz administration. Although there is evidence from isolated rat muscle preparations that V O 2 may be increased by as Table 4 ). http://jap.physiology.org/ much as 27% after CA inhibition, this increase appears to be a function of the fiber type (i.e., oxidative fibers demonstrate increased V O 2 after CA inhibition) and the amount and activity of the intracellular CA isozyme (i.e., CA III) (17) . Alternatively, the degree of intracellular CA inhibition may be minor compared with the inhibition of erythrocyte and extracellular CA isozymes, and thus the effect on V O 2 by this mechanism may be small. Furthermore, several muscle groups of mixed-fiber composition are involved in cycle ergometer exercise in humans, and therefore any difference in V O 2 as a result of CA inhibition may not be detectable on examination of pulmonary V O 2 .
V O 2 on-transient kinetics. The results of the present study demonstrate that the kinetics of the V O 2 on-response for ϽV ET and ϾV ET exercise were not affected by CA inhibition, despite reductions in [La Ϫ ] pl early in exercise. These findings are in contrast to previous studies demonstrating a close association between V O 2 on-kinetics and early blood La Ϫ accumulation (11, 12, 14) . An increase in blood [La Ϫ ] during the transition may be a consequence of inadequate O 2 delivery or an inability to utilize O 2 and PCr stores at a rate sufficient to support ATP production without any contribution from anaerobic glycolysis. Cerretelli and di Prampero (10) proposed a control model that suggested V O 2 on-kinetics were slowed as a consequence of ATP production by anaerobic glycolysis. According to their control model, the metabolic drive for oxidative phosphorylation was related to a net increase in free creatine (Cr) and a decrease in PCr. They hypothesized that regeneration of ATP by anaerobic glycolysis would not only result in La Ϫ production but would attenuate the increase in Cr and decrease in PCr, thereby slowing the V O 2 on-kinetics by reducing the drive for oxidative phosphorylation. Although this mechanism is consis- tent with the observation of slowed V O 2 on-kinetics in association with early La Ϫ accumulation (11, 12, 14) , the lower [La Ϫ ] pl during Acz in the present study was not associated with a faster V O 2 on-response. If in our study the lower [La Ϫ ] pl during Acz reflects a lower intramuscular La Ϫ production, then this suggests that V O 2 during the on-transition is independent of La Ϫ accumulation and that the energy derived from anaerobic glycolysis does not spare or slow O 2 utilization. However, if La Ϫ production was similar in Con and Acz conditions but La Ϫ efflux from muscle was impaired during Acz, then the similar V O 2 kinetics observed for the on-transitions would be appropriate. Using an isolated muscle preparation, De Hemptinne et al. (13) demonstrated that during recovery from an induced propionic acid load the muscle surface pH transiently acidified (independent of the acid-base status of the bulk solution) and that the sarcolemmal acidification was magnified in the presence of Acz. A similar mechanism acting in vivo during Acz may explain the lower [La Ϫ ] pl in this study. Inhibition of the outward-facing sarcolemmal CA IV isozyme may lead to increased acidification on the extracellular surface as acid equivalents generated during heavy-intensity exercise are transported from the muscle interior. An increased acidification on the muscle surface may act to inhibit La Ϫ efflux, inasmuch as the monocarboxylate transporter and diffusion of undissociated lactic acid are slowed by an extracellular acidosis (20) . However, this mechanism remains speculative, inasmuch as muscle La Ϫ production during acute Acz administration has not been examined previously.
For heavy-intensity exercise at ϾV ET, characterizing the V O 2 on-response is further complicated because of an additional increase in V O 2 of delayed onset that results in a higher asymptotic value for V O 2 than that predicted from the V O 2 -power output relationship for ϽV ET exercise (2, 6, 40, 41) . Phase 2 kinetics have been reported to be longer than (19, 29) or similar to (2, 6, 8) the response during ϽV ET exercise and to be closely associated with increases in end-exercise [La Ϫ ] pl (2, 8, 9) . In the present study the longer MRT for the ϾV ET on-transient demonstrates that the overall rate of adaptation was slowed compared with ϽV ET exercise. In addition, values for 2 indicate that the primary increase in V O 2 was also slowed during the step increase in ϾV ET exercise compared with ϽV ET exercise, despite the gain (i.e., G 2 ) projecting to similar ⌬V O 2 /⌬ work rate values (9.7 Ϯ 0.4 and 10.4 Ϯ 1.1 ml · min Ϫ1 ·W Ϫ1 for ϽV ET and ϾV ET, respectively). This finding is in agreement with the results of Paterson and Whipp (29) , who included only data between 20 s and 3 min of the on-transient to eliminate any confounding influence that inclusion of phase 1 or phase 3 would have on determining the model parameters. They suggested that the longer phase 2 kinetics during ϾV ET exercise reflected slowed O 2 utilization and, therefore, would be consistent with increases in muscle and plasma La Ϫ . In addition, using sinusoidal forcing functions to avoid development of the slow component, Haouzi and co-workers (19) demonstrated a slowing of V O 2 kinetics for ϾV ET exercise. In contrast to these studies, Barstow and colleagues (2, 6) argued that the kinetics of the primary rise in V O 2 (i.e., phase 2) were invariant across power outputs and end-exercise [La Ϫ ] pl . Possible explanations for the differences observed between studies are unclear. However, a slowing of V O 2 kinetics in this exercise intensity domain is consistent with a slower rate of PCr breakdown (27) Table 3 ). † Significantly different from off-transient.
MRT than ϽV ET exercise, the fast recovery phase (i.e., phase 2) was similar between exercise intensities, as indicated by the similar 2 . In addition, recovery from ϾV ET exercise was faster than the onset of exercise as indicated by the faster MRT and 2 . These results are consistent with previous studies demonstrating a slowed recovery from ϾV ET exercise compared with recovery from moderate-intensity exercise (29) but are inconsistent with findings of symmetrical on-and off-transients during heavy-intensity exercise (3). The similar offtransient kinetics of phase 2 across exercise intensities found in this study may reflect the restoration of PCr and venous O 2 stores to preexercise levels. However, evidence indicates that PCr recovery may be slowed after high-intensity exercise (27) , suggesting that the rate of oxidative phosphorylation may not reflect the rate of PCr resynthesis after heavy-intensity exercise.
The V O 2 slow component is delayed relative to the onset of exercise (TD 3 ϭ 121.2-146.5 s); however, during recovery the time delay for the slow recovery phase (TD 3 ϭ 22.2-24.8 s) converged toward TD 2 (26) is equivalent to the oxidative removal of La Ϫ formed during exercise and the subsequent conversion of La Ϫ to glycogen. Further investigations utilizing onand off-transients during heavy-intensity exercise to determine the relationship between oxidative phosphorylation (i.e., V O 2 kinetics), PCr degradation-resynthesis, and anaerobic glycolysis-gluconeogenesis are warranted.
V O 2 slow component. Contrary to our hypothesis, the magnitude and time course of the V O 2 slow component to the overall V O 2 response were not affected by CA inhibition. Although the time course of the slow component has been well described (2, 8) and was shown to arise predominantly from the exercising muscle (31), the underlying mechanism(s) of the slow component is not clearly evident (see Refs. 16 (Table 5 ; P ϭ 0.055), strongly suggests that V O 2 was actually higher relative to the change in [La Ϫ ] pl during Acz.
The results of the present study provide evidence against the proposal made by Wasserman and colleagues (38) that there is a direct link between the increase in blood [La Ϫ ] and the slow component. They suggest that the lactic acidosis and consequent decrease in arterial pH associated with heavy-intensity exercise result in a rightward shift in the oxyhemoglobin dissociation curve in the capillaries of exercising muscles, thereby allowing a greater unloading of O 2 (i.e., Bohr effect) and aerobic ATP resynthesis (38) . In blood the Bohr effect involves the diffusion of CO 2 and O 2 through the erythrocyte membrane and cytoplasm as well as the generation of H ϩ from the intracellular CO 2 hydration-dehydration reaction. The kinetics of this process are sufficiently fast so that, under normal conditions, equilibrium is reached within the capillary transit time of 0.75-1 s (25) . However, when CA is completely inhibited, the generation of H ϩ from the hydration of CO 2 is slowed, and therefore the rate of O 2 off-loading may also be slowed (15) . Maren and Swenson (25) noted that, in humans, there is an ϳ360-fold excess of erythrocyte CA activity, such that the Bohr effect may proceed normally and CO 2 hydration is not rate limiting. We observed that V CO 2 kinetics were slowed during the on-transient, suggesting that CO 2 hydration may be slowed (unpublished observations). Inasmuch as the V O 2 slow component was not affected by CA inhibition (either in kinetics or magnitude), this suggests that the Bohr effect is not altered by CA inhibition at the level of the muscle or, alternatively, the Bohr effect does not contribute to the development of the V O 2 slow component.
Summary. In conclusion, Acz-induced CA inhibition resulted in lower [La Ϫ ] pl during moderate-and heavyintensity exercise but did not affect V O 2 on-or offtransition kinetics at either exercise intensity. Compared with moderate-intensity exercise, phase 2 and MRT were slowed for V O 2 kinetics during the ontransition to heavy-intensity exercise. Recovery from heavy-intensity exercise was associated with slower V O 2 off-kinetics with no difference between Con and Acz; the slower off-kinetics were due to the appearance of a slow recovery phase (i.e., phase 3), since the kinetics of the fast recovery phase (i.e., phase 2) were similar to those observed after moderate-intensity exercise. The longer kinetics of the slow phase of recovery were not associated with an elevated [La Ϫ ] pl . The dissociation between the V O 2 slow component and [La Ϫ ] pl suggests that mechanisms other than plasma La Ϫ appearance or the associated change in acid-base status determine the time course and magnitude of the slow component.
